Clinical Trial Update: Temozolomide,Thiotepa and Carboplatin With Autologous Stem Cell Rescue Followed by 13-cis-retinoic Acid in Patients With Recurrent/Refractory Malignant Brain Tumors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a multimodal regimen (temozolomide, thiotepa, carboplatin with autologous stem cell rescue followed by 13-cis-retinoic acid) f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumors

Drugs mentioned

• 13-cis-retinoic acid (13-cis-retinoic acid)
• Autologous stem cell rescue
• CARBOPLATIN (Carboplatin)
• THIOTEPA (THIOTEPA)
• Temozolomide (Temozolomide)

Snippet

Sponsor: NYU Langone Health | Conditions: Brain Tumors | Phase 2 | Status: COMPLETED | Results posted: 2021-07-08